Literature DB >> 22137229

Inherited epidermolysis bullosa: new diagnostic criteria and classification.

Lizbeth R A Intong1, Dédée F Murrell.   

Abstract

Epidermolysis bullosa (EB) is a group of inherited, mechanobullous disorders caused by mutations in various structural proteins in the skin. There have been several advances in the classification of EB since it was first introduced in the late 19th century. We now recognize four major types of EB, depending on the location of the target proteins and level of the blisters: EB simplex (epidermolytic), junctional EB (lucidolytic), dystrophic EB (dermolytic), and Kindler syndrome (mixed levels of blistering). This contribution will summarize the most recent classification and discuss the molecular basis, target genes, and proteins involved. We have also included new subtypes, such as autosomal dominant junctional EB and autosomal recessive EB due to mutations in the dystonin (DST) gene, which encodes the epithelial isoform of bullouspemphigoid antigen 1. The main laboratory diagnostic techniques-immunofluorescence mapping, transmission electron microscopy, and mutation analysis-will also be discussed. Finally, the clinical characteristics of the different major EB types and subtypes will be reviewed.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22137229     DOI: 10.1016/j.clindermatol.2011.03.012

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  36 in total

1.  Renal involvement in epidermolysis bullosa simplex: an unusual presentation.

Authors:  K N Harikrishnan; Sriram Krishnamurthy; Nachiappa Ganesh Rajesh; Subramanian Mahadevan
Journal:  Indian J Pediatr       Date:  2012-11-16       Impact factor: 1.967

2.  Dental and Anaesthetic Challenges in a Patient with Dystrophic Epidermolysis Bullosa.

Authors:  Ali Al-Abadi; Salah A Al-Azri; Abdulaziz Bakathir; Yusra Al-Riyami
Journal:  Sultan Qaboos Univ Med J       Date:  2016-11-30

3.  Birmingham epidermolysis severity score and vitamin D status are associated with low BMD in children with epidermolysis bullosa.

Authors:  G Rodari; S Guez; F Manzoni; K K Chalouhi; E Profka; S Bergamaschi; S Salera; G Tadini; F M Ulivieri; A Spada; C Giavoli; S Esposito
Journal:  Osteoporos Int       Date:  2016-12-23       Impact factor: 4.507

4.  Distinct Impact of Two Keratin Mutations Causing Epidermolysis Bullosa Simplex on Keratinocyte Adhesion and Stiffness.

Authors:  Melanie Homberg; Lena Ramms; Nicole Schwarz; Georg Dreissen; Rudolf E Leube; Rudolf Merkel; Bernd Hoffmann; Thomas M Magin
Journal:  J Invest Dermatol       Date:  2015-05-11       Impact factor: 8.551

Review 5.  A practical approach to the evaluation and treatment of an infant with aplasia cutis congenita.

Authors:  S R Humphrey; X Hu; K Adamson; A Schaus; J N Jensen; B Drolet
Journal:  J Perinatol       Date:  2017-10-19       Impact factor: 2.521

Review 6.  Epidermolysis bullosa and the partnership with autoimmunity: what should we assimilate?

Authors:  Susanna Esposito; Sophie Guez; Francesca Manzoni; Annalisa Bosco; Donato Rigante
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 7.  Molecular therapeutics for heritable skin diseases.

Authors:  Jouni Uitto
Journal:  J Invest Dermatol       Date:  2012-11-15       Impact factor: 8.551

8.  Collagen VII plays a dual role in wound healing.

Authors:  Alexander Nyström; Daniela Velati; Venugopal R Mittapalli; Anja Fritsch; Johannes S Kern; Leena Bruckner-Tuderman
Journal:  J Clin Invest       Date:  2013-07-08       Impact factor: 14.808

9.  Interaction of plectin with keratins 5 and 14: dependence on several plectin domains and keratin quaternary structure.

Authors:  Jamal-Eddine Bouameur; Bertrand Favre; Lionel Fontao; Prakash Lingasamy; Nadja Begré; Luca Borradori
Journal:  J Invest Dermatol       Date:  2014-06-18       Impact factor: 8.551

10.  ITGB6 loss-of-function mutations cause autosomal recessive amelogenesis imperfecta.

Authors:  Shih-Kai Wang; Murim Choi; Amelia S Richardson; Bryan M Reid; Brent P Lin; Susan J Wang; Jung-Wook Kim; James P Simmer; Jan C-C Hu
Journal:  Hum Mol Genet       Date:  2013-12-04       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.